| abstract |
FIELD: medicine. n SUBSTANCE: group of inventions relates to agent containing or consisting of (a) antibody or its antigen-binding fragment with specificity to human glandular kallikrein (hK2) and (b) cytotoxic molecules for treating prostate cancer, method of treating prostate cancer, which involves stage of administering therapeutically effective amount of agent containing or consisting of (a) antibody or its antigen-binding fragment with specificity to human glandular kallikrein (hK2) and (b) cytotoxic molecules, as well as composition and kit for treating prostate cancer. n EFFECT: group of inventions is aimed at mitigation, reducing or eliminating deficiencies in treating prostate cancer. n 78 cl, 50 dwg, 4 tbl, 10 ex |